Nirupam Purkayastha Selected Research

2- (4- (4- chlorophenyl)piperazin- 1- ylmethyl)pyrazolo(1,5- a)- pyridine

1/2017

Development of molecular tools based on the dopamine D3 receptor ligand FAUC 329 showing inhibiting effects on drug and food maintained behavior.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nirupam Purkayastha Research Topics

Disease

2	Parkinson Disease (Parkinson's Disease) 12/2020 - 01/2017
2	Schizophrenia (Dementia Praecox) 12/2020 - 12/2016
1	Necrosis 01/2021
1	Synovitis 01/2021
1	Psoriatic Arthritis 01/2021
1	Mental Disorders (Mental Disorder) 12/2020
1	Substance-Related Disorders (Drug Abuse) 01/2017
1	Inflammation (Inflammations) 01/2014
1	Malaria 10/2013
1	Tuberculosis (Tuberculoses) 10/2013

Drug/Important Bio-Agent (IBA)

3	Biological ProductsIBA 01/2021 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2020
1	Interleukin-23 (Interleukin 23)IBA 01/2021
1	Ustekinumab (CNTO 1275)FDA Link 01/2021
1	LigandsIBA 01/2017
1	2- (4- (4- chlorophenyl)piperazin- 1- ylmethyl)pyrazolo(1,5- a)- pyridineIBA 01/2017
1	Dopamine D3 ReceptorsIBA 01/2017
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2017
1	Dopamine Receptors (Dopamine Receptor)IBA 12/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2014
1	octaarginineIBA 10/2013
1	Pharmaceutical PreparationsIBA 10/2013
1	fosmidomycinIBA 10/2013

Therapy/Procedure

1	Therapeutics 12/2020